Karen Lee, DPM
Foot Surgery · Pembroke Pines, FLNPI 1730137969
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (45.6%), education and travel and lodging — rather than concentrated in one kind of arrangement. 42 manufacturers reported payments, led by Arthrex at 44.9% of the total. Reporting peaked in 2022 at $5,652 and has fallen 94.7% since, to $300 in 2025. Among foot surgery clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 212 payments — averaging $55.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$5K
- Paragon 28, Inc.$1K
- Amgen$1K
- Organogenesis Inc.$439
- Polynovo North America LLC$379
- Amniox Medical, Inc.$364
- plus $3K from 36 others
What the payments were for
- Speaking & faculty fees$811%
- Travel & lodging$1,50713%
- Food & beverage$5,34846%
- Education$4,80041%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Portfolio$1,192
- RAYOS$329
- NEOX$277
- CLARIX$277
- KRYSTEXXA$223
- Novosorb BTM$198
- AUGMENT INJECTABLE$159
- Actishield$159
- CLAW II$159
- EASYFUSE$159
- QUANTUM$134
- COLINK 2$134
- IN2BONES USA$134
- Dermagraft$125
- Licart$125
- PuraPly AM$111
- DALVANCE$102
How this compares
$11,735 in reported general payments places this provider in the 90th percentile of 107 foot surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 428 | $6,167 |
| Ammonium Lactate | 49 | $517 |
| Mupirocin | 35 | $194 |
| Allopurinol | 14 | $105 |
| Naproxen | 14 | $58 |
Paid to pharmacies, not to this prescriber.
Other foot surgery in Pembroke Pines
- Melissa PerlmanPembroke Pines$7K
- Larry HodsonPanama City$413K
- Bret BrennanTampa$60K
- Bradley HerbstJacksonville$20K
- Amy DunetzAventura$14K
- Than Binh NguyenTampa$13K
- Orlando CedenoJupiter$13K
- Nicole GortaireSt Augustine$11K
- Alix CharlesPlantation$8K
- Allison GuyenMiami Beach$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.